Sinopharm Group Co. Ltd.

SHTDY · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$47,157$54,313$43,332$63,809
Short-Term Investments$0$0$1$1
Receivables$244,129$206,721$242,411$185,790
Inventory$65,520$62,353$68,838$60,028
Other Curr. Assets$17,090$24,060$27,782$27,208
Total Curr. Assets$373,897$347,448$382,363$336,835
Property Plant & Equip (Net)$15,897$19,632$20,099$19,898
Goodwill$6,203$6,252$0$7,186
Intangibles$3,998$4,718$10,124$2,830
Long-Term Investments$10,550$10,894$10,600$10,551
Tax Assets$0$2,408$0$0
Other NC Assets$9,623$1,479$6,398$6,095
Total NC Assets$46,270$45,384$47,220$46,560
Other Assets$0$0$0$0
Total Assets$420,168$392,831$429,583$383,395
Liabilities
Payables$152,673$156,870$155,835$154,747
Short-Term Debt$85,914$64,490$81,450$56,527
Tax Payable$0$0$0$2,989
Deferred Revenue$0$0$0$0
Other Curr. Liab.$41,196$29,016$45,953$27,228
Total Curr. Liab.$279,782$250,376$283,238$241,491
LT Debt$7,381$11,897$19,606$17,255
Deferred Rev, NC$0$0$0$448
Deferred Tax Liab, NC$0$0$0$788
Other NC Liab.$3,532$3,872$4,307$3,094
Total NC Liab.$10,913$15,768$23,912$21,585
Other Liabilities$0$0$0$0
Cap. Leases$2,945$5,020$5,441$5,217
Total Liabilities$290,695$266,144$307,150$263,076
Equity
Pref Stock$0$0$0$0
Common Stock$3,121$3,121$3,121$3,121
Retained Earnings$56,791$53,745$50,399$49,410
AOCI$20$22,022$22,026$0
Other Equity$20,450-$4-$4$22,052
Total Equity$80,382$78,884$75,542$74,582
Supplemental Information
Minority Interest$49,090$47,804$46,891$45,737
Total Liab. & Tot. Equity$420,168$392,831$429,583$383,395
Net Debt$46,137$22,073$57,723$9,973